chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Pain in jaw, Wrong drug administered
Clinical narrative: Initial report was received 11 June and 15 June 2009 from a consumer, who is the patient's parent. A female patient (age not reported) had received an injection of MENACTRA (lot number, route and site not reported) on 06 June 2009 and an unspecified amount of time later, she developed "a little jaw pain" . The patient received MENACTRA in error, instead of a chicken pox booster. No other adverse events occurred. The patient's recovery status was not reported. Follow up information received on 02 July 2009 from a health care professional who reported that the 16 year old patient received a second dose of MENACTRA (lot number U2915AA) in the left arm. The patient recovered. No further information was reported.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Lymphadenopathy
Clinical narrative: Initial report received on 26 June 2009 from a health care professional. A female patient had received a dose of MENACTRA (lot number and route not reported) in the right arm on 22 June 2009. At an unspecified amount of time later, the patient developed adenopathy of the right axilla. Treatments received and diagnostic tests preformed were not reported. The reporter was unable to provide any other information. Recovery status was not reported. Follow up information was received on 03 Sep 2009 from a health care professional regarding an 18 year old female patient. Lot number for MENACTRA administered was U2636AA and the route of administration was intramuscular. The patient recovered from the event. No further information was provided. Documents held by sender: none.
Age: 45.0
Sex: F
Vaccine: HEP, MNQ, TDAP
Symptoms: Injection site swelling
Clinical narrative: Initial report received on 01 July 2009 from a health care professional.  A 47 year old female patient received ADACEL (lot number C3066), MENACTRA (U2915AA) both intramuscularly in the right deltoid, and RECOMBIVAX (lot number 0438Y) intramuscularly in the left deltoid on 26 June 2009 at 09:00 PM.  Post vaccination, the patient developed a lump at the injection site, specific arm was not specified.  The lump persisted at the time of the report.  No further information was provided.  Follow up information received on 17 July 2009 from a health care professional who reported that the number of previous doses of vaccine were unknown.  The patient experienced a lump at the right deltoid on 13 July 2009.  The patient had improved by the time she was seen in the health center.  The patient did not receive treatment.  No further information was provided.  Follow up information received on 24 July 2009 from a health care professional who stated that the patient was seen for a visit in the health center on 20 July 2009.  At the time of the visit, her condition was improved.  The patient did not return for further follow up.  No further information was provided.  List of Documents held by Sender:  none.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Dizziness, Pallor, Sensory loss, Vision blurred
Clinical narrative: Initial report received on 31 July 2009 from a health care professional. A 12-year-old male patient, who had no concurrent illnesses, pre-existing medical conditions, or use of other medications had received on 30 July 2009 an intramuscular left deltoid injection of ADACEL (lot number C2862AA); an intramuscular left deltoid injection of MENACTRA (lot number U2656AA); and an intramuscular right deltoid injection of VARIVAX (manufacturer Merck, lot number 0193Y). Per the reporter, on 30 July 2009 the patient had received the vaccines and became pale, lightheaded, had blurred vision and could not feel his arms and legs. The symptoms lasted four minutes and the patient fully recovered. It was not reported whether the patient required any medical interventions at the time. Documents held by sender: None.
Age: 32.0
Sex: M
Vaccine: MNQ
Symptoms: Asthenia, Diarrhoea, Rhinitis
Clinical narrative: Initial report received 06 August 2009 from a health care professional. A 32-year-old male patient had received a first dose intramuscular injection of MENACTRA, lot number U2924AA on 04 August 2009, and two days later on 06 August 2009 at 02:00 hours, he developed diarrhea, weakness and rhinitis. The patient had also received an injection of Hepatitis B vaccine on 05 August 2009, twelve hours prior to the onset of symptoms. The patient had been taking TRAMADOL concomitantly at the time of vaccination and they had no past medical history and no concomitant illness. At the time of the report, their recovery status was unknown. Follow-up information received 27 October 2009 from a health care professional. Hepatitis B vaccine (lot number 0438Y, manufacturer Merck) had been an intramuscular right deltoid injection. According to the reporter, the patient recovered on 07 August 2009. No additional information was provided.
Age: 13.0
Sex: M
Vaccine: MNQ
Symptoms: Alopecia, Blood aluminium increased
Clinical narrative: Initial report received on 14 August 2009 from a physician.  A 14 year old male patient, whose medical history was unknown, received a first intramuscular injection of MENACTRA (lot number U2868AA) on 16 March 2009.  It was unknown if the patient had an illness at the time of vaccination.  In June 2009, the patient developed alopecia on the head and increased levels of aluminum in the blood.  At the time of the report, the patient had not yet been seen by the physician.  The patient's outcome was unknown.  No further information was available at the time of the report.
Sex: F
Vaccine: FLU3, MNQ, TDAP, FLU3
Symptoms: Chills, Cough, Dyspnoea, Pain, Reaction to previous exposure to any vaccine
Clinical narrative: A female patient (age not reported) received ADACEL, FLUZONE and MENACTRA (lot numbers not reported) on 11 February 2009 in the afternoon. That evening, at approximately 23:00 hours, she noted some blurred vision. The following morning her vision was very blurred, so she contacted her physician who prescribed over-the-counter VISINE eye drops. The patient also noted chills, aches, cough and mild shortness of breath following the vaccinations, which she reported was typical for her. The patient fully recovered within 24 hours. Additional events for this same patient are recorded in case 2009-05361. Documents held by sender: None.
Sex: F
Vaccine: FLU3, MNQ, TDAP, FLU3
Symptoms: Vision blurred
Clinical narrative: A female patient (age not reported) received ADACEL, FLUZONE and MENACTRA (lot numbers not reported) on 11 February 2009 in the afternoon. That evening, at approximately 23:00 hours, she noted some blurred vision. The following morning her vision was very blurred, so she contacted her physician who prescribed over-the-counter VISINE eye drops. The patient also noted chills, aches, cough and mild shortness of breath following the vaccinations, which she reported was typical for her. The patient fully recovered within 24 hours. Additional events for this same patient are recorded in case 2009-05361. Documents held by sender: None.
Sex: F
Vaccine: FLU3, MNQ, TDAP, FLU3
Symptoms: Chills, Cough, Dyspnoea, Pain, Vision blurred
Clinical narrative: A female patient (age not reported) received ADACEL, FLUZONE and MENACTRA (lot numbers not reported) on 11 February 2009 in the afternoon. That evening, at approximately 23:00 hours, she noted some blurred vision. The following morning her vision was very blurred, so she contacted her physician who prescribed over-the-counter VISINE eye drops. The patient also noted chills, aches, cough and mild shortness of breath following the vaccinations, which she reported was typical for her. The patient fully recovered within 24 hours. Additional events for this same patient are recorded in case 2009-05361. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: MNQ
Symptoms: Rash erythematous, Rash papular, Rash pustular
Clinical narrative: This non-serious event was received from a nurse practitioner on 03 February 2009. A 21-year-old male patient, with no reported history, received an intramuscular right deltoid injection of MENACTRA (lot number J2866AA) on 30 January 2009. The next day, on 31 January 2009, he developed a red raised, papular rash with some pustules over the upper anterior one-third of his chest. The rash was not itchy or warm to the touch, and the patient was afebrile. At the time of the report, the rash had not gotten worse, but remained ongoing. the patient had been referred to a dermatologist.
Age: 16.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Drug exposure during pregnancy, Iron deficiency
Clinical narrative: Initial report received on 09 October 2009 from a health care professional. A 16 year old female patient, with no medical conditions or allergies, received a right arm 0.5 ml intramuscular injection of MENACTRA (lot number U2908AA) on 16 September 2009 as part as part of routine immunization. The patient was pregnant at the time of vaccination. Concomitant medications included FERROUS SULFATE 325mg. Her last menstrual period was either 15 or 19 August 2009 and her expected date of confinement is 26 May 2010. Prenatal testing was not reported. The patient had no previous pregnancies. No adverse event was reported. The patient had no previous pregnancies. No adverse event was reported. Follow up information received on 28 December 2009 from a health care professional. The patient had a questionable history of high blood pressure and no known use of recreational drugs or alcohol. The patient's last date of her menstrual period was 19 August 2009 and estimated date of delivery was 26 May 2010. In addition to receiving MENACTRA, the patient also received a first dose of Tdap (manufacturer not provided, lot number AC52B036BA) and a third dose of GARDASIL (manufacturer Merck, lot number 0100X) on 16 September 2009. The patient was reported as having an iron deficiency during the pregnancy (onset date not provided) and was being treated with iron. The reporter stated that at the time of the last attempt in contacting the patient, the patient had still not received prenatal care at that time.
Age: 13.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Anaemia, Drug exposure during pregnancy, Haematocrit decreased, Haemoglobin decreased, Laboratory test normal
Clinical narrative: Initial report received on 27 October 2009 from a healthcare professional. A 13 year old female patient with no previous history of pregnancies and a "negative" medical history received MENACTRA (lot number U2925AA) and BOOSTRIX (manufacturer GSK, lot number AC52B045BA) on 16 September 2009. On 27 October 2009, the reporter discovered that the patient was 29 weeks pregnant. At the time of vaccination, the patient was 24 weeks pregnant. Date of last menstrual period and estimated date of confinement were not reported. Information regarding tobacco, alcohol, and recreational drug use were unknown. At the time of the report, the patient had not experienced any adverse events following vaccinations on 16 September 2009. Follow-up information was received from a healthcare professional on 28 December 2009. The reporter noted that the patient was unaware of her pregnancy, and did not access prenatal care until 29.4 weeks gestation. On 08 October 2009 she underwent an ultrasound, which showed normal fetal anatomy, normal AFI (13.73 cm), and normal placenta (grade 0). All labs were normal, except for hematocrit (29.4) and hemoglobin (9.3). The patient was diagnosed with severe anemia. No additional information was reported.
Age: 13.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Ultrasound antenatal screen normal
Clinical narrative: Initial report received on 27 October 2009 from a healthcare professional. A 13 year old female patient with no previous history of pregnancies and a "negative" medical history received MENACTRA (lot number U2925AA) and BOOSTRIX (manufacturer GSK, lot number AC52B045BA) on 16 September 2009. On 27 October 2009, the reporter discovered that the patient was 29 weeks pregnant. At the time of vaccination, the patient was 24 weeks pregnant. Date of last menstrual period and estimated date of confinement were not reported. Information regarding tobacco, alcohol, and recreational drug use were unknown. At the time of the report, the patient had not experienced any adverse events following vaccinations on 16 September 2009. Follow-up information was received from a healthcare professional on 28 December 2009. The reporter noted that the patient was unaware of her pregnancy, and did not access prenatal care until 29.4 weeks gestation. On 08 October 2009 she underwent an ultrasound, which showed normal fetal anatomy, normal AFI (13.73 cm), and normal placenta (grade 0). All labs were normal, except for hematocrit (29.4) and hemoglobin (9.3). The patient was diagnosed with severe anemia. No additional information was reported.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Cytomegalovirus test negative, Depression, Epstein-Barr virus antibody negative, Full blood count normal, Metabolic function test
Clinical narrative: Initial report received on 04 November 2009 from a healthcare professional. A 17 year old male patient, with no known allergies and no medical history, received a first intramuscular left deltoid injection of MENACTRA (lot number U3079AA) on 26 October 2009. On the eve of vaccination, the patient had weird dreams, and upon awakening the next morning, he had a fever (temperature not reported), muscle cramps and he became depressed. He was seen at his doctor's office on 02 November 2009 and symptoms were still persisting at that time. At the time of the report, 04 November 2009, the patient's recovery status was reported as unknown. Follow-up information received on 07 December 2009 from a health care professional. The patient had diagnostic tests of CBC, CMP, CMV virus, and "EBV-1SM" on 02 November 2009 that were negative. Per the reporter by phone discussion on 08 November 2009 the patient had recovered.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Muscle spasms, Pyrexia
Clinical narrative: Initial report received on 04 November 2009 from a healthcare professional. A 17 year old male patient, with no known allergies and no medical history, received a first intramuscular left deltoid injection of MENACTRA (lot number U3079AA) on 26 October 2009. On the eve of vaccination, the patient had weird dreams, and upon awakening the next morning, he had a fever (temperature not reported), muscle cramps and he became depressed. He was seen at his doctor's office on 02 November 2009 and symptoms were still persisting at that time. At the time of the report, 04 November 2009, the patient's recovery status was reported as unknown. Follow-up information received on 07 December 2009 from a health care professional. The patient had diagnostic tests of CBC, CMP, CMV virus, and "EBV-1SM" on 02 November 2009 that were negative. Per the reporter by phone discussion on 08 November 2009 the patient had recovered.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Diarrhoea, Grand mal convulsion, Reaction to previous exposure to any vaccine, Vomiting
Clinical narrative: Initial report was received 02 March 2010 from a consumer, who is the patient's father. A 16-year-old male patient had received a left deltoid intramuscular injection of MENACTRA, lot number U2930AA on 20 July 2009 at 7:17pm and five days later, he developed vomiting and diarrhea. The following morning he experienced a grand mal seizure. The event required an emergency room visit and corrective treatments consisted of DILANTIN. Diagnostic and laboratory data were unknown. The patient had a past history of a sulfa allergy and he had no illness at the time of vaccination. The patient subsequently experienced a similar event after receiving a dose of H1N1 vaccine (manufacturer sanofi pasteur, lot number UP001AA) on 30 October 2009 which has been captured in case number 2010-01335. According to the reporter, the patient had been evaluated by a neurologist and at the time of the report, he had not recovered. This patient experienced another serious adverse event which has been captured in case number 2010-01335. Documents held by sender: None.
Age: 15.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Conversion disorder, Convulsion, Depressed level of consciousness, Dyspnoea, Pallor
Clinical narrative: Client received H1N1 vaccine 05 ml @9:45 a.m. Came to see nurse @ 11:55 am c/o vomiting and wanting to go home. Juice given - student stated the she felt the same way when she had other medicine (?dye) in past, at 11:08 am PHN called over. Student pale, semi conscious and having seizure type activity. PHN and school nurse could get her to respond by nodding and she lifted arm for BP. Nodded head to SOB and throat closing. Epinephrine given @ 12:12. Rescue squad called/mom called when incident began. To hospital via squad @ 11:20 am.
Age: 15.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Throat tightness, Vomiting
Clinical narrative: Client received H1N1 vaccine 05 ml @9:45 a.m. Came to see nurse @ 11:55 am c/o vomiting and wanting to go home. Juice given - student stated the she felt the same way when she had other medicine (?dye) in past, at 11:08 am PHN called over. Student pale, semi conscious and having seizure type activity. PHN and school nurse could get her to respond by nodding and she lifted arm for BP. Nodded head to SOB and throat closing. Epinephrine given @ 12:12. Rescue squad called/mom called when incident began. To hospital via squad @ 11:20 am.
Age: 2.0
Sex: M
Vaccine: FLU3, HEPA, FLU3, HEPA, HIBV
Symptoms: Injection site swelling, Swelling
Clinical narrative: Rt arm and part of Rt chest swollen after vaccine. Right arm up to wrist and up to the center of chest with significant erythema and swelling.
Age: 2.0
Sex: M
Vaccine: FLU3, HEPA, FLU3, HEPA, HIBV
Symptoms: Chest discomfort, Injection site erythema, Injection site swelling, White blood cell count increased
Clinical narrative: Rt arm and part of Rt chest swollen after vaccine. Right arm up to wrist and up to the center of chest with significant erythema and swelling.
Sex: U
Vaccine: HEPA, MNQ, MNQ
Symptoms: Abasia, Dyspnoea, Dysstasia, Hypoaesthesia, Lumbar puncture
Clinical narrative: Initial report was received on 03 March 2010 from a healthcare professional. It contains information for a cluster of a "few" unidentified patients. The reporter stated that there was a "rumor" in the community, that a "few" unidentified "children" received an injection (unspecified route and site) of the same lot number of MENACTRA (lot number not reported) on an unspecified date. The rumor included one child on a respirator in the hospital and other children who "got very, very ill." No other information was provided. The reporter did not want to be contacted and would not give a full address. Documents held by sender: None.
Sex: U
Vaccine: HEPA, MNQ, MNQ
Symptoms: Mobility decreased, Muscle spasms, Muscular weakness, Nerve conduction studies, Nuclear magnetic resonance imaging
Clinical narrative: Initial report was received on 03 March 2010 from a healthcare professional. It contains information for a cluster of a "few" unidentified patients. The reporter stated that there was a "rumor" in the community, that a "few" unidentified "children" received an injection (unspecified route and site) of the same lot number of MENACTRA (lot number not reported) on an unspecified date. The rumor included one child on a respirator in the hospital and other children who "got very, very ill." No other information was provided. The reporter did not want to be contacted and would not give a full address. Documents held by sender: None.
Sex: U
Vaccine: HEPA, MNQ, MNQ
Symptoms: Malaise
Clinical narrative: Initial report was received on 03 March 2010 from a healthcare professional. It contains information for a cluster of a "few" unidentified patients. The reporter stated that there was a "rumor" in the community, that a "few" unidentified "children" received an injection (unspecified route and site) of the same lot number of MENACTRA (lot number not reported) on an unspecified date. The rumor included one child on a respirator in the hospital and other children who "got very, very ill." No other information was provided. The reporter did not want to be contacted and would not give a full address. Documents held by sender: None.
Age: 38.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Breast pain, Mammogram normal, Pyrexia
Clinical narrative: Subjective fever, and R breast pain 2-3 days after immunization. Breast pain continued about 10 days. No abscess or findings on exam.
Age: 0.17
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, RV5, DTAP, HEP, HIBV, IPV, PNC, RV5
Symptoms: Death
Clinical narrative: Information has been received from a physician concerning a 16 week old male patient, who on 09-FEB-2010 was vaccinated with a dose of RECOMBIVAX HB (dose and route not reported, lot number: 666025/1274Y). Suspect vaccine administered on the same day, 09-FEB-2010, included a dose of ROTATEQ (MSD) (dose, lot number and route not reported (duration and dose not reported). Other concomitant vaccines administered on the same day, 09-FEB-2010, included a dose of ACTHIB, DTAP-IPV and PREVNAR. The office manager reported that the patient passed away (date and cause of death was unspecified) after getting RECOMBIVAX HB, ROTATEQ, ACTHIB, DTAP-IPV and PREVNAR. No laboratory test was performed. The patient sought unspecified medical attention. The adverse event of death was considered to be immediately life-threatening by the reporter. A lot check has been initiated. Additional information has been requested.
Age: 1.25
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Pyrexia
Clinical narrative: Fever at 37.5 degrees Celsius.
Age: 1.61
Sex: M
Vaccine: DTAPIPVHIB, MMR, PNC, VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Breakthrough case of varicella
Age: 4.0
Sex: M
Vaccine: DTAP, HEPA, IPV
Symptoms: Activities of daily living impaired, Arthralgia, Asthenia, Body temperature, Decreased appetite
Clinical narrative: Began with soreness in the left lef where the shot was given, gave 1 tsp of Motrin.  The next day patient complained of that his left knee was hurting and all the joints in his left arm.  His left leg was swollen to almost twice the size of his right leg and he had a temp. of 100.1, gave him Motrin and warm compresses, call his primary dr.  Thursday, March 11th, his leg is still extremely swollen and he has a lack of energy and appetite, saw his dr. at 11:30 AM, and was told to continue with Motrin and warm compresses.  As of today, March 12th, his leg is still swollen, it is actually getting bigger and he can not climb up to his top bunk bed.
Age: 4.0
Sex: M
Vaccine: DTAP, HEPA, IPV
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Began with soreness in the left lef where the shot was given, gave 1 tsp of Motrin.  The next day patient complained of that his left knee was hurting and all the joints in his left arm.  His left leg was swollen to almost twice the size of his right leg and he had a temp. of 100.1, gave him Motrin and warm compresses, call his primary dr.  Thursday, March 11th, his leg is still extremely swollen and he has a lack of energy and appetite, saw his dr. at 11:30 AM, and was told to continue with Motrin and warm compresses.  As of today, March 12th, his leg is still swollen, it is actually getting bigger and he can not climb up to his top bunk bed.
Age: 28.0
Sex: M
Vaccine: FLU(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Anti-GAD antibody positive, Areflexia, Ataxia, Back pain, Bacterial test negative
Clinical narrative: The pt arrived on 1/4/10. He received multiple vaccinations on 1/5/20 at which time he was healthy. He had no adverse reactions. On 1/7/10 he noted that he felt feverish, chilled, had a sore throat, rhinorrhea, slight cough, and body aches which lasted about 4 days. There were other people around him who were also sick. On 2/12/10 the pt received multiple vaccinations. On 2/14/10, the patient experienced fever, chills, diaphoresis, severe sore throat, cough and generalized body aches. He does not recall that others were also sick. On 2/20/10 the pt noted numbness on the bottom of his feet and his fingertips. 2/21/10 he also noted numbness of his lips, tongue and blurry vision. On 2/22/10 he was treated in the ER for a sinus infection and was instructed to follow-up in the am for his neurological symptoms. On 2/23/10 the pt was seen in medical for a headache, blurry vision and numbness/tingling of the bottom of his feet, mouth, and fingertips. The pt was evaluated by a neurologist. PE revealed "stocking loss of sensation in association with areflexia in the legs; subtle breakdown in smooth pursuits coinciding with blurred vision." A NCS was performed. It was felt that the pt most likely had Guillain-Barre syndrome but his symptoms were so mild that treatment was not warranted so the pt was returned went to work with instructions to f/u in 2 days. The pt returned to medical on 2/24/10 with complaints of headache, difficulty walking, numbness in his calves, anus, scrotum and worsening of his blurry vision. He denied bowel or bladder incontinence but he did have urinary hesitancy. The pt was reevaluated by the neurologist and released due to "no progression in his paresthesias". The patient was admitted to the hospital for observation. The physical exam revealed distal areflexia, ataxic gait, instability with Romberg testing, muscle strength and tone was 5/5 and symmetric in BLE/BUE. Over the next 48 hours the patient's symptoms progressed to include onset of LBP, generalized myalgias, perioral and facial numbness, difficulty managing his oral secretions and coughing with intake of liquids. On 2/26/10 PE revealed normal BLE/BUE muscle strength and tone, weakness of facial muscles, diminished corneal reflexes, mild dysarthria. The pt was transferred to another hospital with complaints of numbness of his finger tips, feet, legs, hips, pelvis, abdomen up to the rib cage, and difficulty swallowing and talking due to numbness of his mouth and lips, and blurry vision. He was diagnosed with Miller-Fisher variant of Guillain-Barre syndrome. The pt was treated with IVIG 0.8mg/kg daily for 3 days. As of 3/8/10 the pt's headaches were being treated with IMITREX, there was improvement of the facial paresis and pt was ambulating with a cane. Symptoms: numbness, dysphagia, headache, general, numbness, numbness, blurred vision, numbness, fever, chills, diaphoresis, pain, muscle pain, cough, productive, fever, chills, pain, nasal drainage, cough, productive, muscle pain.
Age: 28.0
Sex: M
Vaccine: FLU(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Blood glucose increased, Blood urea increased, Chest X-ray normal, Chills, Corneal reflex decreased
Clinical narrative: The pt arrived on 1/4/10. He received multiple vaccinations on 1/5/20 at which time he was healthy. He had no adverse reactions. On 1/7/10 he noted that he felt feverish, chilled, had a sore throat, rhinorrhea, slight cough, and body aches which lasted about 4 days. There were other people around him who were also sick. On 2/12/10 the pt received multiple vaccinations. On 2/14/10, the patient experienced fever, chills, diaphoresis, severe sore throat, cough and generalized body aches. He does not recall that others were also sick. On 2/20/10 the pt noted numbness on the bottom of his feet and his fingertips. 2/21/10 he also noted numbness of his lips, tongue and blurry vision. On 2/22/10 he was treated in the ER for a sinus infection and was instructed to follow-up in the am for his neurological symptoms. On 2/23/10 the pt was seen in medical for a headache, blurry vision and numbness/tingling of the bottom of his feet, mouth, and fingertips. The pt was evaluated by a neurologist. PE revealed "stocking loss of sensation in association with areflexia in the legs; subtle breakdown in smooth pursuits coinciding with blurred vision." A NCS was performed. It was felt that the pt most likely had Guillain-Barre syndrome but his symptoms were so mild that treatment was not warranted so the pt was returned went to work with instructions to f/u in 2 days. The pt returned to medical on 2/24/10 with complaints of headache, difficulty walking, numbness in his calves, anus, scrotum and worsening of his blurry vision. He denied bowel or bladder incontinence but he did have urinary hesitancy. The pt was reevaluated by the neurologist and released due to "no progression in his paresthesias". The patient was admitted to the hospital for observation. The physical exam revealed distal areflexia, ataxic gait, instability with Romberg testing, muscle strength and tone was 5/5 and symmetric in BLE/BUE. Over the next 48 hours the patient's symptoms progressed to include onset of LBP, generalized myalgias, perioral and facial numbness, difficulty managing his oral secretions and coughing with intake of liquids. On 2/26/10 PE revealed normal BLE/BUE muscle strength and tone, weakness of facial muscles, diminished corneal reflexes, mild dysarthria. The pt was transferred to another hospital with complaints of numbness of his finger tips, feet, legs, hips, pelvis, abdomen up to the rib cage, and difficulty swallowing and talking due to numbness of his mouth and lips, and blurry vision. He was diagnosed with Miller-Fisher variant of Guillain-Barre syndrome. The pt was treated with IVIG 0.8mg/kg daily for 3 days. As of 3/8/10 the pt's headaches were being treated with IMITREX, there was improvement of the facial paresis and pt was ambulating with a cane. Symptoms: numbness, dysphagia, headache, general, numbness, numbness, blurred vision, numbness, fever, chills, diaphoresis, pain, muscle pain, cough, productive, fever, chills, pain, nasal drainage, cough, productive, muscle pain.
Age: 28.0
Sex: M
Vaccine: FLU(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Cough, Dysarthria, Dysphagia, Facial paresis, Gait disturbance
Clinical narrative: The pt arrived on 1/4/10. He received multiple vaccinations on 1/5/20 at which time he was healthy. He had no adverse reactions. On 1/7/10 he noted that he felt feverish, chilled, had a sore throat, rhinorrhea, slight cough, and body aches which lasted about 4 days. There were other people around him who were also sick. On 2/12/10 the pt received multiple vaccinations. On 2/14/10, the patient experienced fever, chills, diaphoresis, severe sore throat, cough and generalized body aches. He does not recall that others were also sick. On 2/20/10 the pt noted numbness on the bottom of his feet and his fingertips. 2/21/10 he also noted numbness of his lips, tongue and blurry vision. On 2/22/10 he was treated in the ER for a sinus infection and was instructed to follow-up in the am for his neurological symptoms. On 2/23/10 the pt was seen in medical for a headache, blurry vision and numbness/tingling of the bottom of his feet, mouth, and fingertips. The pt was evaluated by a neurologist. PE revealed "stocking loss of sensation in association with areflexia in the legs; subtle breakdown in smooth pursuits coinciding with blurred vision." A NCS was performed. It was felt that the pt most likely had Guillain-Barre syndrome but his symptoms were so mild that treatment was not warranted so the pt was returned went to work with instructions to f/u in 2 days. The pt returned to medical on 2/24/10 with complaints of headache, difficulty walking, numbness in his calves, anus, scrotum and worsening of his blurry vision. He denied bowel or bladder incontinence but he did have urinary hesitancy. The pt was reevaluated by the neurologist and released due to "no progression in his paresthesias". The patient was admitted to the hospital for observation. The physical exam revealed distal areflexia, ataxic gait, instability with Romberg testing, muscle strength and tone was 5/5 and symmetric in BLE/BUE. Over the next 48 hours the patient's symptoms progressed to include onset of LBP, generalized myalgias, perioral and facial numbness, difficulty managing his oral secretions and coughing with intake of liquids. On 2/26/10 PE revealed normal BLE/BUE muscle strength and tone, weakness of facial muscles, diminished corneal reflexes, mild dysarthria. The pt was transferred to another hospital with complaints of numbness of his finger tips, feet, legs, hips, pelvis, abdomen up to the rib cage, and difficulty swallowing and talking due to numbness of his mouth and lips, and blurry vision. He was diagnosed with Miller-Fisher variant of Guillain-Barre syndrome. The pt was treated with IVIG 0.8mg/kg daily for 3 days. As of 3/8/10 the pt's headaches were being treated with IMITREX, there was improvement of the facial paresis and pt was ambulating with a cane. Symptoms: numbness, dysphagia, headache, general, numbness, numbness, blurred vision, numbness, fever, chills, diaphoresis, pain, muscle pain, cough, productive, fever, chills, pain, nasal drainage, cough, productive, muscle pain.
Age: 28.0
Sex: M
Vaccine: FLU(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Haematocrit decreased, Haemophilus infection, Headache, Hyperhidrosis, Hypoaesthesia
Clinical narrative: The pt arrived on 1/4/10. He received multiple vaccinations on 1/5/20 at which time he was healthy. He had no adverse reactions. On 1/7/10 he noted that he felt feverish, chilled, had a sore throat, rhinorrhea, slight cough, and body aches which lasted about 4 days. There were other people around him who were also sick. On 2/12/10 the pt received multiple vaccinations. On 2/14/10, the patient experienced fever, chills, diaphoresis, severe sore throat, cough and generalized body aches. He does not recall that others were also sick. On 2/20/10 the pt noted numbness on the bottom of his feet and his fingertips. 2/21/10 he also noted numbness of his lips, tongue and blurry vision. On 2/22/10 he was treated in the ER for a sinus infection and was instructed to follow-up in the am for his neurological symptoms. On 2/23/10 the pt was seen in medical for a headache, blurry vision and numbness/tingling of the bottom of his feet, mouth, and fingertips. The pt was evaluated by a neurologist. PE revealed "stocking loss of sensation in association with areflexia in the legs; subtle breakdown in smooth pursuits coinciding with blurred vision." A NCS was performed. It was felt that the pt most likely had Guillain-Barre syndrome but his symptoms were so mild that treatment was not warranted so the pt was returned went to work with instructions to f/u in 2 days. The pt returned to medical on 2/24/10 with complaints of headache, difficulty walking, numbness in his calves, anus, scrotum and worsening of his blurry vision. He denied bowel or bladder incontinence but he did have urinary hesitancy. The pt was reevaluated by the neurologist and released due to "no progression in his paresthesias". The patient was admitted to the hospital for observation. The physical exam revealed distal areflexia, ataxic gait, instability with Romberg testing, muscle strength and tone was 5/5 and symmetric in BLE/BUE. Over the next 48 hours the patient's symptoms progressed to include onset of LBP, generalized myalgias, perioral and facial numbness, difficulty managing his oral secretions and coughing with intake of liquids. On 2/26/10 PE revealed normal BLE/BUE muscle strength and tone, weakness of facial muscles, diminished corneal reflexes, mild dysarthria. The pt was transferred to another hospital with complaints of numbness of his finger tips, feet, legs, hips, pelvis, abdomen up to the rib cage, and difficulty swallowing and talking due to numbness of his mouth and lips, and blurry vision. He was diagnosed with Miller-Fisher variant of Guillain-Barre syndrome. The pt was treated with IVIG 0.8mg/kg daily for 3 days. As of 3/8/10 the pt's headaches were being treated with IMITREX, there was improvement of the facial paresis and pt was ambulating with a cane. Symptoms: numbness, dysphagia, headache, general, numbness, numbness, blurred vision, numbness, fever, chills, diaphoresis, pain, muscle pain, cough, productive, fever, chills, pain, nasal drainage, cough, productive, muscle pain.
Age: 28.0
Sex: M
Vaccine: FLU(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Paraesthesia, Paraesthesia oral, Platelet count increased, Positive Rombergism, Productive cough
Clinical narrative: The pt arrived on 1/4/10. He received multiple vaccinations on 1/5/20 at which time he was healthy. He had no adverse reactions. On 1/7/10 he noted that he felt feverish, chilled, had a sore throat, rhinorrhea, slight cough, and body aches which lasted about 4 days. There were other people around him who were also sick. On 2/12/10 the pt received multiple vaccinations. On 2/14/10, the patient experienced fever, chills, diaphoresis, severe sore throat, cough and generalized body aches. He does not recall that others were also sick. On 2/20/10 the pt noted numbness on the bottom of his feet and his fingertips. 2/21/10 he also noted numbness of his lips, tongue and blurry vision. On 2/22/10 he was treated in the ER for a sinus infection and was instructed to follow-up in the am for his neurological symptoms. On 2/23/10 the pt was seen in medical for a headache, blurry vision and numbness/tingling of the bottom of his feet, mouth, and fingertips. The pt was evaluated by a neurologist. PE revealed "stocking loss of sensation in association with areflexia in the legs; subtle breakdown in smooth pursuits coinciding with blurred vision." A NCS was performed. It was felt that the pt most likely had Guillain-Barre syndrome but his symptoms were so mild that treatment was not warranted so the pt was returned went to work with instructions to f/u in 2 days. The pt returned to medical on 2/24/10 with complaints of headache, difficulty walking, numbness in his calves, anus, scrotum and worsening of his blurry vision. He denied bowel or bladder incontinence but he did have urinary hesitancy. The pt was reevaluated by the neurologist and released due to "no progression in his paresthesias". The patient was admitted to the hospital for observation. The physical exam revealed distal areflexia, ataxic gait, instability with Romberg testing, muscle strength and tone was 5/5 and symmetric in BLE/BUE. Over the next 48 hours the patient's symptoms progressed to include onset of LBP, generalized myalgias, perioral and facial numbness, difficulty managing his oral secretions and coughing with intake of liquids. On 2/26/10 PE revealed normal BLE/BUE muscle strength and tone, weakness of facial muscles, diminished corneal reflexes, mild dysarthria. The pt was transferred to another hospital with complaints of numbness of his finger tips, feet, legs, hips, pelvis, abdomen up to the rib cage, and difficulty swallowing and talking due to numbness of his mouth and lips, and blurry vision. He was diagnosed with Miller-Fisher variant of Guillain-Barre syndrome. The pt was treated with IVIG 0.8mg/kg daily for 3 days. As of 3/8/10 the pt's headaches were being treated with IMITREX, there was improvement of the facial paresis and pt was ambulating with a cane. Symptoms: numbness, dysphagia, headache, general, numbness, numbness, blurred vision, numbness, fever, chills, diaphoresis, pain, muscle pain, cough, productive, fever, chills, pain, nasal drainage, cough, productive, muscle pain.
Age: 28.0
Sex: M
Vaccine: FLU(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Pyrexia, Rhinorrhoea, Salivary hypersecretion, Sensory loss, Sinusitis
Clinical narrative: The pt arrived on 1/4/10. He received multiple vaccinations on 1/5/20 at which time he was healthy. He had no adverse reactions. On 1/7/10 he noted that he felt feverish, chilled, had a sore throat, rhinorrhea, slight cough, and body aches which lasted about 4 days. There were other people around him who were also sick. On 2/12/10 the pt received multiple vaccinations. On 2/14/10, the patient experienced fever, chills, diaphoresis, severe sore throat, cough and generalized body aches. He does not recall that others were also sick. On 2/20/10 the pt noted numbness on the bottom of his feet and his fingertips. 2/21/10 he also noted numbness of his lips, tongue and blurry vision. On 2/22/10 he was treated in the ER for a sinus infection and was instructed to follow-up in the am for his neurological symptoms. On 2/23/10 the pt was seen in medical for a headache, blurry vision and numbness/tingling of the bottom of his feet, mouth, and fingertips. The pt was evaluated by a neurologist. PE revealed "stocking loss of sensation in association with areflexia in the legs; subtle breakdown in smooth pursuits coinciding with blurred vision." A NCS was performed. It was felt that the pt most likely had Guillain-Barre syndrome but his symptoms were so mild that treatment was not warranted so the pt was returned went to work with instructions to f/u in 2 days. The pt returned to medical on 2/24/10 with complaints of headache, difficulty walking, numbness in his calves, anus, scrotum and worsening of his blurry vision. He denied bowel or bladder incontinence but he did have urinary hesitancy. The pt was reevaluated by the neurologist and released due to "no progression in his paresthesias". The patient was admitted to the hospital for observation. The physical exam revealed distal areflexia, ataxic gait, instability with Romberg testing, muscle strength and tone was 5/5 and symmetric in BLE/BUE. Over the next 48 hours the patient's symptoms progressed to include onset of LBP, generalized myalgias, perioral and facial numbness, difficulty managing his oral secretions and coughing with intake of liquids. On 2/26/10 PE revealed normal BLE/BUE muscle strength and tone, weakness of facial muscles, diminished corneal reflexes, mild dysarthria. The pt was transferred to another hospital with complaints of numbness of his finger tips, feet, legs, hips, pelvis, abdomen up to the rib cage, and difficulty swallowing and talking due to numbness of his mouth and lips, and blurry vision. He was diagnosed with Miller-Fisher variant of Guillain-Barre syndrome. The pt was treated with IVIG 0.8mg/kg daily for 3 days. As of 3/8/10 the pt's headaches were being treated with IMITREX, there was improvement of the facial paresis and pt was ambulating with a cane. Symptoms: numbness, dysphagia, headache, general, numbness, numbness, blurred vision, numbness, fever, chills, diaphoresis, pain, muscle pain, cough, productive, fever, chills, pain, nasal drainage, cough, productive, muscle pain.
Age: 28.0
Sex: M
Vaccine: FLU(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Speech disorder, Sputum culture positive, Urinary hesitation, Vision blurred, Walking aid user
Clinical narrative: The pt arrived on 1/4/10. He received multiple vaccinations on 1/5/20 at which time he was healthy. He had no adverse reactions. On 1/7/10 he noted that he felt feverish, chilled, had a sore throat, rhinorrhea, slight cough, and body aches which lasted about 4 days. There were other people around him who were also sick. On 2/12/10 the pt received multiple vaccinations. On 2/14/10, the patient experienced fever, chills, diaphoresis, severe sore throat, cough and generalized body aches. He does not recall that others were also sick. On 2/20/10 the pt noted numbness on the bottom of his feet and his fingertips. 2/21/10 he also noted numbness of his lips, tongue and blurry vision. On 2/22/10 he was treated in the ER for a sinus infection and was instructed to follow-up in the am for his neurological symptoms. On 2/23/10 the pt was seen in medical for a headache, blurry vision and numbness/tingling of the bottom of his feet, mouth, and fingertips. The pt was evaluated by a neurologist. PE revealed "stocking loss of sensation in association with areflexia in the legs; subtle breakdown in smooth pursuits coinciding with blurred vision." A NCS was performed. It was felt that the pt most likely had Guillain-Barre syndrome but his symptoms were so mild that treatment was not warranted so the pt was returned went to work with instructions to f/u in 2 days. The pt returned to medical on 2/24/10 with complaints of headache, difficulty walking, numbness in his calves, anus, scrotum and worsening of his blurry vision. He denied bowel or bladder incontinence but he did have urinary hesitancy. The pt was reevaluated by the neurologist and released due to "no progression in his paresthesias". The patient was admitted to the hospital for observation. The physical exam revealed distal areflexia, ataxic gait, instability with Romberg testing, muscle strength and tone was 5/5 and symmetric in BLE/BUE. Over the next 48 hours the patient's symptoms progressed to include onset of LBP, generalized myalgias, perioral and facial numbness, difficulty managing his oral secretions and coughing with intake of liquids. On 2/26/10 PE revealed normal BLE/BUE muscle strength and tone, weakness of facial muscles, diminished corneal reflexes, mild dysarthria. The pt was transferred to another hospital with complaints of numbness of his finger tips, feet, legs, hips, pelvis, abdomen up to the rib cage, and difficulty swallowing and talking due to numbness of his mouth and lips, and blurry vision. He was diagnosed with Miller-Fisher variant of Guillain-Barre syndrome. The pt was treated with IVIG 0.8mg/kg daily for 3 days. As of 3/8/10 the pt's headaches were being treated with IMITREX, there was improvement of the facial paresis and pt was ambulating with a cane. Symptoms: numbness, dysphagia, headache, general, numbness, numbness, blurred vision, numbness, fever, chills, diaphoresis, pain, muscle pain, cough, productive, fever, chills, pain, nasal drainage, cough, productive, muscle pain.
Age: 28.0
Sex: M
Vaccine: FLU(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: White blood cell count increased
Clinical narrative: The pt arrived on 1/4/10. He received multiple vaccinations on 1/5/20 at which time he was healthy. He had no adverse reactions. On 1/7/10 he noted that he felt feverish, chilled, had a sore throat, rhinorrhea, slight cough, and body aches which lasted about 4 days. There were other people around him who were also sick. On 2/12/10 the pt received multiple vaccinations. On 2/14/10, the patient experienced fever, chills, diaphoresis, severe sore throat, cough and generalized body aches. He does not recall that others were also sick. On 2/20/10 the pt noted numbness on the bottom of his feet and his fingertips. 2/21/10 he also noted numbness of his lips, tongue and blurry vision. On 2/22/10 he was treated in the ER for a sinus infection and was instructed to follow-up in the am for his neurological symptoms. On 2/23/10 the pt was seen in medical for a headache, blurry vision and numbness/tingling of the bottom of his feet, mouth, and fingertips. The pt was evaluated by a neurologist. PE revealed "stocking loss of sensation in association with areflexia in the legs; subtle breakdown in smooth pursuits coinciding with blurred vision." A NCS was performed. It was felt that the pt most likely had Guillain-Barre syndrome but his symptoms were so mild that treatment was not warranted so the pt was returned went to work with instructions to f/u in 2 days. The pt returned to medical on 2/24/10 with complaints of headache, difficulty walking, numbness in his calves, anus, scrotum and worsening of his blurry vision. He denied bowel or bladder incontinence but he did have urinary hesitancy. The pt was reevaluated by the neurologist and released due to "no progression in his paresthesias". The patient was admitted to the hospital for observation. The physical exam revealed distal areflexia, ataxic gait, instability with Romberg testing, muscle strength and tone was 5/5 and symmetric in BLE/BUE. Over the next 48 hours the patient's symptoms progressed to include onset of LBP, generalized myalgias, perioral and facial numbness, difficulty managing his oral secretions and coughing with intake of liquids. On 2/26/10 PE revealed normal BLE/BUE muscle strength and tone, weakness of facial muscles, diminished corneal reflexes, mild dysarthria. The pt was transferred to another hospital with complaints of numbness of his finger tips, feet, legs, hips, pelvis, abdomen up to the rib cage, and difficulty swallowing and talking due to numbness of his mouth and lips, and blurry vision. He was diagnosed with Miller-Fisher variant of Guillain-Barre syndrome. The pt was treated with IVIG 0.8mg/kg daily for 3 days. As of 3/8/10 the pt's headaches were being treated with IMITREX, there was improvement of the facial paresis and pt was ambulating with a cane. Symptoms: numbness, dysphagia, headache, general, numbness, numbness, blurred vision, numbness, fever, chills, diaphoresis, pain, muscle pain, cough, productive, fever, chills, pain, nasal drainage, cough, productive, muscle pain.